Net Cash Provided by (Used in) Financing Activities of BIOETHICS LTD from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIOETHICS LTD annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • BIOETHICS LTD Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $5,850, a 95% increase year-over-year.
  • BIOETHICS LTD annual Net Cash Provided by (Used in) Financing Activities for 2024 was $164,955, a 645% increase from 2023.
  • BIOETHICS LTD annual Net Cash Provided by (Used in) Financing Activities for 2023 was $22,150, a 12% decline from 2022.
  • BIOETHICS LTD annual Net Cash Provided by (Used in) Financing Activities for 2022 was $25,200, a 8.5% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

BIOETHICS LTD Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $164,955 +$142,805 +645% 01 Jan 2024 31 Dec 2024 10-K 13 Aug 2025 2024 FY
2023 $22,150 -$3,050 -12% 01 Jan 2023 31 Dec 2023 10-K 13 Aug 2025 2024 FY
2022 $25,200 -$2,350 -8.5% 01 Jan 2022 31 Dec 2022 10-K 11 Apr 2024 2023 FY
2021 $27,550 -$33,050 -55% 01 Jan 2021 31 Dec 2021 10-K 17 Apr 2023 2022 FY
2020 $60,600 +$4,286 +7.6% 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2022 2021 FY
2019 $56,314 -$17,606 -24% 01 Jan 2019 31 Dec 2019 10-K 15 Apr 2021 2020 FY
2018 $73,920 +$66,920 +956% 01 Jan 2018 31 Dec 2018 10-K 09 Apr 2020 2019 FY
2017 $7,000 -$28,000 -80% 01 Jan 2017 31 Dec 2017 10-K 19 Mar 2019 2018 FY
2016 $35,000 -$65,000 -65% 01 Jan 2016 31 Dec 2016 10-K 17 Apr 2018 2017 FY
2015 $100,000 +$58,862 +143% 01 Jan 2015 31 Dec 2015 10-K 07 Apr 2017 2016 FY
2014 $41,138 +$31,138 +311% 01 Jan 2014 31 Dec 2014 10-K 13 Apr 2016 2015 FY
2013 $10,000 -$10,000 -50% 01 Jan 2013 31 Dec 2013 10-K 21 Mar 2014 2013 FY
2012 $20,000 -$5,000 -20% 01 Jan 2012 31 Dec 2012 10-K 21 Mar 2014 2013 FY
2011 $25,000 $0 0% 01 Jan 2011 31 Dec 2011 10-K 29 Mar 2013 2012 FY
2010 $25,000 01 Jan 2010 31 Dec 2010 10-K 30 Mar 2012 2011 FY

BIOETHICS LTD Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $5,850 +$2,850 +95% 01 Jan 2024 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q1 2023 $3,000 -$150 -4.8% 01 Jan 2023 31 Mar 2023 10-Q 20 May 2024 2024 Q1
Q1 2022 $3,150 -$250 -7.4% 01 Jan 2022 31 Mar 2022 10-Q/A 23 May 2023 2023 Q1
Q1 2021 $3,400 -$3,000 -47% 01 Jan 2021 31 Mar 2021 10-Q 23 May 2022 2022 Q1
Q1 2020 $6,400 -$43,600 -87% 01 Jan 2020 31 Mar 2020 10-Q/A 27 May 2021 2021 Q1
Q1 2019 $50,000 +$41,500 +488% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q1 2018 $8,500 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q1 2015 $0 -$11,000 -100% 01 Jan 2015 31 Mar 2015 10-Q 15 May 2015 2015 Q1
Q1 2014 $11,000 +$11,000 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q1 2013 $0 $0 01 Jan 2013 31 Mar 2013 10-Q 20 May 2014 2014 Q1
Q1 2012 $0 $0 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013 2013 Q1
Q1 2011 $0 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.